Skip to main content

Advertisement

SpringerLink
Log in

Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma

  • Original Paper
  • Published:
Journal of Molecular Histology Aims and scope Submit manuscript

Abstract

The assessment of caveolin-1 (Cav-1) as a marker of tumor aggressiveness in pancreatic ductal adenocarcinoma (PDAC). In this study, we examined the expression of Cav-1 in 34 human PDAC tissue samples and the associated peritumoral tissues by immunohistochemistry and western blot. Additionally, we correlated Cav-1 expression with other tissue (Ki-67, p53) and serum (CA 19-9) tumor markers. In the tumor-derived tissue, both tumor cells and blood vessels expressed Cav-1. In contrast, in peritumoral tissue, Cav-1 expression was confined mainly to blood vessels and was only occasionally expressed in ductal or parenchymal cells. Western blot analysis confirmed the overexpression of Cav-1 in pancreatic tumors compared with peritumoral tissue. Cav-1 expression in tumor tissues was correlated with both the Ki-67 LI (r = 0.95, P < 0.0001) and p53 expression (χ2 = 9.91, P < 0.005). Overexpression of Cav-1 was associated with tumor size, grade and stage and Cav-1 expression in tumors was correlated with an increased serum level of CA 19-9 (r = 0.795, P < 0.001). Based on the results of this study, the inclusion of Cav-1 in a putative panel of biomarkers predicting pancreatic cancer aggressiveness is warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Anderson RG, Jacobson K (2002) A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296:1821–1825. doi:10.1126/science.1068886

    Article  PubMed  CAS  Google Scholar 

  • Barresi V, Cerasoli S, Paioli G, Vitarelli E, Giuffre G, Guiducci G, Tuccari G, Barresi G (2006) Caveolin-1 in meningiomas: expression and clinico-pathological correlations. Acta Neuropathol 112:617–626. doi:10.1007/s00401-006-0097-1

    Article  PubMed  CAS  Google Scholar 

  • Belanger MM, Roussel E, Couet J (2004) Caveolin-1 is down-regulated in human lung carcinoma and acts as a candidate tumor suppressor gene. Chest 125:106S. doi:10.1378/chest.125.5_suppl.106S

    Article  PubMed  Google Scholar 

  • Bender FC, Reymond MA, Bron C, Quest AF (2000) Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res 60:5870–5878

    PubMed  CAS  Google Scholar 

  • Burgermeister E, Xing X, Rocken C, Juhasz M, Chen J, Hiber M, Mair K, Shatz M, Liscovitch M, Schmid RM, Ebert MP (2007) Differential expression and function of caveolin-1 in human gastric cancer progression. Cancer Res 67:8519–8526. doi:10.1158/0008-5472.CAN-07-1125

    Article  PubMed  CAS  Google Scholar 

  • Burgermeister E, Liscovitch M, Röcken C, Schmid R, Ebert M (2008) Caveats of caveolin-1 in cancer progression. Cancer Lett 268(2):187–201. doi:10.1016/j.canlet.2008.03.055

    Article  PubMed  CAS  Google Scholar 

  • Cassoni P, Senetta R, Castellano I, Ortolan E, Bosco M, Magnani I, Ducati A (2007) Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas. Am J Surg Pathol 31:760–769. doi:10.1097/01.pas.0000213433.14740.5d

    Article  PubMed  Google Scholar 

  • Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, Lisanti MP (1998) Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett 428:205–211. doi:10.1016/S0014-5793(98)00470-0

    Article  PubMed  CAS  Google Scholar 

  • Fong A, Garcia E, Gwynn L, Lisanti MP, Fazzari MJ, Li M (2003) Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation. Am J Clin Pathol 120:93–100. doi:10.1309/292NHAYNWAVREJ37

    Article  PubMed  CAS  Google Scholar 

  • Galbiati F, Volonte D, Brown AM, Weinstein DE, Ben-Ze’ev A, Pestell RG, Lisanti MP (2000) Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains. J Biol Chem 275:23368–23377. doi:10.1074/jbc.M002020200

    Article  PubMed  CAS  Google Scholar 

  • Goetz JG, Lajoie P, Wiseman SM, Nabi IR (2008) Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev 27(4):715–735. doi:10.1007/s10555-008-9160-9

    Article  PubMed  CAS  Google Scholar 

  • Goonetilleke KS, Siriwardena AK (2007) Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 33:266–270. doi:10.1016/j.ejso.2006.10.004

    Article  PubMed  CAS  Google Scholar 

  • Hsu SM, Raine L, Fanger H (1981) Use of avidin–biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580

    PubMed  CAS  Google Scholar 

  • Jeong S, Lee DH, Lee JI, Lee JW, Kwon KS, Kim PS, Kim HG, Shin YW, Kim YS, Kim YB (2005) Expression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma. World J Gastroenterol 11:6765–6769

    PubMed  CAS  Google Scholar 

  • Kato K, Hida Y, Miyamoto M, Hashida H, Shinohara T, Itoh T, Okushiba S, Kondo S, Katoh H (2002) Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 94:929–933. doi:10.1002/cncr.10329

    Article  PubMed  CAS  Google Scholar 

  • Kim HA, Kim KH, Lee RA (2006) Expression of caveolin-1 is correlated with Akt-1 in colorectal cancer tissues. Exp Mol Pathol 80:165–170. doi:10.1016/j.yexmp.2005.09.001

    Article  PubMed  CAS  Google Scholar 

  • Liedtke C, Kersting C, Burger H, Kiesel L, Wulfing P (2007) Caveolin-1 expression in benign and malignant lesions of the breast. World J Surg Oncol 5:110. doi:10.1186/1477-7819-5-110

    Article  PubMed  Google Scholar 

  • Lin M, DiVito MM, Merajver SD, Boyanapalli M, van Golen KL (2005) Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Mol Cancer 4:21. doi:10.1186/1476-4598-4-21

    Article  PubMed  Google Scholar 

  • Murakami S, Miyamoto M, Hida Y, Cho Y, Fukunaga A, Oshikiri T, Kato K, Kurokawa T, Suzuoki M, Nakakubo Y, Hiraoka K, Itoh T, Shinohara T, Morikawa T, Okushiba O, Kondo S, Katoh H (2003) Caveolin-I overexpression is a favourable prognostic factor for patients with extrahepatic bile duct carcinoma. Br J Cancer 88:1234–1238

    PubMed  CAS  Google Scholar 

  • Park SS, Kim JE, Kim YA, Kim YC, Kim SW (2005) Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast. Histopathology 47:625–630. doi:10.1111/j.1365-2559.2005.02303.x

    Article  PubMed  Google Scholar 

  • Perrone G, Altomare V, Zagami M, Morini S, Petitti T, Battista C, Muda AO, Rabitti C (2009) Caveolin-1 expression in human breast lobular cancer progression. Mod Pathol 22(1):71–78

    Article  PubMed  CAS  Google Scholar 

  • Quest AF, Gutierrez-Pajares JL, Torres VA (2008) Caveolin-1: an ambiguous partner in cell signalling and cancer. J Cell Mol Med 12(4):1130–1150. doi:10.1111/j.1582-4934.2008.00331.x

    Article  PubMed  CAS  Google Scholar 

  • Stanton KJ, Sidner RA, Miller GA, Cummings OW, Schmidt CM, Howard TJ, Wiebke EA (2003) Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas. Am J Surg 186:486–492. doi:10.1016/j.amjsurg.2003.07.002

    Article  PubMed  CAS  Google Scholar 

  • Suzuoki M, Miyamoto M, Kato K, Hiraoka K, Oshikiri T, Nakakubo Y, Fukunaga A, Shichinohe T, Shinohara T, Itoh T, Kondo S, Katoh H (2002) Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br J Cancer 87:1140–1144. doi:10.1038/sj.bjc.6600619

    Article  PubMed  CAS  Google Scholar 

  • Tamaskar I, Choueiri TK, Sercia L, Rini B, Bukowski R, Zhou M (2007) Differential expression of caveolin-1 in renal neoplasms. Cancer 110:776–782. doi:10.1002/cncr.22838

    Article  PubMed  Google Scholar 

  • Tanase CP (2008) Caveolin-1: a marker for pancreatic cancer diagnosis. Expert Rev Mol Diagn 8:395–404. doi:10.1586/14737159.8.4.395

    Article  PubMed  CAS  Google Scholar 

  • Terris B, Blaveri E, Crnogorac-Jurcevic T, Jones M, Missiaglia E, Ruszniewski P, Sauvanet A, Lemoine NR (2002) Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am J Pathol 160:1745–1754

    PubMed  CAS  Google Scholar 

  • Warshaw AL, Fernandez-del Castillo C (1992) Pancreatic carcinoma. N Engl J Med 326:455–465

    PubMed  CAS  Google Scholar 

  • Wiechen K, Diatchenko L, Agoulnik A, Scharff KM, Schober H, Arlt K, Zhumabayeva B, Siebert PD, Dietel M, Schafer R, Sers C (2001a) Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol 159:1635–1643

    PubMed  CAS  Google Scholar 

  • Wiechen K, Sers C, Agoulnik A, Arlt K, Dietel M, Schlag PM, Schneider U (2001b) Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol 158:833–839

    PubMed  CAS  Google Scholar 

  • Williams TM, Lisanti MP (2005) Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 288:C494–C506. doi:10.1152/ajpcell.00458.2004

    Article  PubMed  CAS  Google Scholar 

  • Witkiewicz AK, Nguyen K, Dasgupta A, Kennedy EP, Yeo CJ, Lisanti MP, Brody JR (2008) Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: Implications for tumor progression and clinical outcome. Cell Cycle 7(19):3021–3025

    PubMed  CAS  Google Scholar 

  • Yang G, Addai J, Wheeler TM, Frolov A, Miles BJ, Kadmon D, Thompson TC (2007) Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis. Hum Pathol 38:1688–1695. doi:10.1016/j.humpath.2007.03.024

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Work supported by the National Romanian Authority for Scientific Research, Research for excellence Program, Project CEEX 64/2006. We thank Mrs. Olivia Sgarbura for her support in statistical analysis.

Author information

Authors and Affiliations

  1. “Victor Babes” National Institute of Pathology, 99-101 Splaiul Independentei, Bucharest, 050096, Romania

    Cristiana Pistol Tanase, Mihaela Mihai, Elena Raducan, Mihnea Ioan Nicolescu, Lucian Albulescu, Mircea Leabu & Mihail Eugen Hinescu

  2. Fundeni Clinical Institute, 258 Soseaua Fundeni, Bucharest, Romania

    Simona Dima, Traian Dumitrascu & Irinel Popescu

  3. Department of Cellular and Molecular Medicine, “Carol Davila” University of Medicine and Pharmacy, 8 Eroilor Sanitari Blvd, Bucharest, Romania

    Mihnea Ioan Nicolescu, Bogdan Voiculescu, Linda Maria Cruceru, Mircea Leabu & Mihail Eugen Hinescu

Authors
  1. Cristiana Pistol Tanase
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Simona Dima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mihaela Mihai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elena Raducan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mihnea Ioan Nicolescu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lucian Albulescu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bogdan Voiculescu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Traian Dumitrascu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Linda Maria Cruceru
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Mircea Leabu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Irinel Popescu
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Mihail Eugen Hinescu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mihail Eugen Hinescu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanase, C.P., Dima, S., Mihai, M. et al. Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma. J Mol Hist 40, 23–29 (2009). https://doi.org/10.1007/s10735-008-9209-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10735-008-9209-7

Keywords

Search

Navigation